EDGAR Filing Documents for 0001193125-06-061463

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-06-061463

Filing Date

2006-03-23

Accepted

2006-03-23 09:53:27

Documents

Group Members

WARBURG PINCUS & CO.WARBURG PINCUS LLCWARBURG PINCUS PARTNERS LLC

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 1 TO SCHEDULE 13D	dsc13da.htm	SC 13D/A	150138
2	COMMON STOCK AND WARRANT PURCHASE AGREEMENT	dex99c.htm	EX-99.C	227621
3	WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF SUNESIS PHARMACEUTICALS, INC.	dex99d.htm	EX-99.D	137030
4	REGISTRATION RIGHTS AGREEMENT	dex99e.htm	EX-99.E	140096
5	LOCK-UP LETTER AGREEMENT	dex99f.htm	EX-99.F	10639
	Complete submission text file	0001193125-06-061463.txt		667389

Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500

SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
Type: SC 13D/A | Act: 34 | File No.: 005-81034 | Film No.: 06705096
SIC: 2834 Pharmaceutical Preparations

Mailing Address

Business Address 466 LEXINGTON AVE. NEW YORK NY 10017 2128780600

WARBURG PINCUS EQUITY PARTNERS LP (Filed by) CIK: 0001075598 (see all company filings)

Type: SC 13D/A